Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
Amneal beat analysts' revenue expectations last quarter, reporting revenues of $784.5 million, up 11.7% year on year. It was a very strong quarter for the company, with a beat of analysts' EPS estimates and full-year revenue guidance slightly topping analysts' expectations. Is Amneal a buy or sell going into earnings? Read our full analysis here, it's free for active Edge members This quarter, the market is expecting Amneal's revenue to grow 10.5% year on year, slowing from the 18.4% increase it recorded in the same quarter last year. Amneal Total Revenue Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Amneal has missed Wall Street's revenue estimates multiple times over the last two years. Looking at Amneal's peers in the pharmaceuticals segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Eli Lilly de
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb (BMY) is a Top-Ranked Momentum Stock: Should You Buy? [Yahoo! Finance]Yahoo! Finance
- SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer [Yahoo! Finance]Yahoo! Finance
- SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast CancerBusiness Wire
- Bristol Myers Squibb (BMY) was upgraded by Royal Bank Of Canada to "hold".MarketBeat
BMY
Earnings
- 2/6/26 - Beat
BMY
Sec Filings
- 2/11/26 - Form 10-K
- 2/5/26 - Form 8-K
- 2/3/26 - Form 4
- BMY's page on the SEC website